In a strategic push to transform India’s pharmaceutical and biotech landscape, the government recently outlined and invited ...

Swiss pharma giant Roche today announced that the first Phase III (FENhance 2) of two pivotal, similarly-designed Phase III ...

French biotech EVerZom has signed its first research partnership with compatriot GENFIT to evaluate EViv, an exosome-based ...

The Association of the British Pharmaceutical Industry has urged the UK government to use the upcoming Budget to address what ...

Positive full results from the NATRON Phase III trial showed AstraZeneca’s Fasenra (benralizumab) demonstrated a ...

A broad majority in the Danish Parliament has reached an agreement on multi-year billion-dollar investments in Danish ...

US obesity drug developer Metsera presented detailed results from two Phase IIb trials for its weight-loss drug candidate, ...

US biopharma BridgeBio Pharma has presented data from the ATTRibute-CM study, showing that acoramidis significantly reduces ...

US biotech Gilead Sciences (Nasdaq: GILD) has suffered another disappointment for its cancer therapy Trodelvy (sacituzumab ...

US oncology company Summit Therapeutics and its partner Akeso have communicated results from the Phase III HARMONi-A trial - ...

Japanese drug major Takeda Friday announced new interim data from the Phase Ib, open-label, proof-of-concept study of ...

US clinical-stage genetic medicines company MeiraGTx Holdings saw its shares rise 15% to $9.74 pre-market today, as it ...